Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01789983 · ClinicalTrials.gov registry record
Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy
A clinical trial of Breast Cancer and Lung Cancer, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- 29
- Enrollment target
- 1
- Study location
NCT01789983: Completed study of Breast Cancer and Lung Cancer, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT01789983 is a study of Breast Cancer and Lung Cancer that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 29 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01789983, a study of Breast Cancer and Lung Cancer, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will look at conducting a medium-intense walking program called Walk With Ease with cancer patients age 60 and above who are starting chemotherapy treatment. We will measure how many of these patients complete their participation in this program.
Primary Outcome
Feasibility will be defined as the proportion of recruited subjects who complete the 6-week WWE program.
Conditions Studied
Interventions
- BEHAVIORAL Walk With Ease Program
- OTHER Collect Blood, GA and Other Survey Tools
Study Locations (1)
North Carolina
- University of North Carolina Cancer Hospital - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2012-10 |
| Est. Completion | 2021-12 |
What the finished NCT01789983 record still lists
NCT01789983 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Walk With Ease Program is the first listed.
NCT01789983 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01789983 about?
NCT01789983 is a clinical study titled "Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy". The study will look at conducting a medium-intense walking program called Walk With Ease with cancer patients age 60 and above who are starting chemotherapy treatment. We will measure how many of these patients complete their participation in this program.
What is the current status of trial NCT01789983?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2012-10. Estimated completion is 2021-12.
What conditions does trial NCT01789983 study?
This clinical trial studies the following conditions: Breast Cancer, Lung Cancer, Colon Cancer.
What interventions are being tested in trial NCT01789983?
The interventions under investigation include: Walk With Ease Program (BEHAVIORAL), Collect Blood, GA and Other Survey Tools (OTHER).
Who is sponsoring clinical trial NCT01789983?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01789983 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01789983's enrollment target sits among peer trials
29 999th of 1224 higher than 221 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia